COMPARISON OF NEW DRUG APPROV AL PROCEDURES AND REGULATORY STRUCTURES IN TURKEY AND CANADA

Main Article Content

Abhisek Shukla

Abstract

A regulatory process, by which a person/organization/sponsor/innovator gets authorization to launch a
drug in the market, is known as drug approval process. Every country has its own regulatory authority, which is
responsible to enforce the rules and regulations and issue the guidelines to regulate the marketing of the drugs. A
drug approval process comprises of various stages: application to conduct clinical trials, conducting clinical trials,
application to marketing authorization of drug and post-marketing studies. The purpose of this article is to present
a concise overview of the drug approval process in Turkey and Canada.
Key Words: Drug approval process, clinical trials, marketing, regulatory authority, post marketing studies.

Article Details

How to Cite
Shukla, A. (2016). COMPARISON OF NEW DRUG APPROV AL PROCEDURES AND REGULATORY STRUCTURES IN TURKEY AND CANADA. International Journal of Pharmaceutical and Biological Science Archive, 1(2). Retrieved from http://ijpba.in/index.php/ijpba/article/view/19
Section
Review Article